Your browser doesn't support javascript.
loading
Changing perspectives: unveiling the risks of ashwagandha-induced hepatotoxicity.
Casiano-Manzano, Sergio; Torres-Larrubia, Macarena; Masa-Caballero, Alberto; Jiménez-Colmenarez, Zuliani; Martín-Noguerol, Elisa; Fernández-Bermejo, Miguel; Solís-Muñoz, Pablo.
Afiliação
  • Casiano-Manzano S; Gastroenterology , Hospital Universitario de Cáceres.
  • Torres-Larrubia M; Gastroenterology , Hospital Universitario de Cáceres.
  • Masa-Caballero A; Gastroenterology, Hospital Universitario de Cáceres.
  • Jiménez-Colmenarez Z; Gastroenterology , Hospital Universitario de Cáceres.
  • Martín-Noguerol E; Gastroenterology , Hospital Universitario de Cáceres.
  • Fernández-Bermejo M; Gastroenterology , Hospital Universitario de Cáceres.
  • Solís-Muñoz P; Gastroenterology , Hospital Universitario de Cáceres.
Rev Esp Enferm Dig ; 2023 Nov 20.
Article em En | MEDLINE | ID: mdl-37982556
ABSTRACT
Ashwagandha, an herb popular in Ayurvedic medicine, is renowned for its health-enhancing properties. However, its association with liver damage in recent years has raised significant concerns, necessitating careful assessment and management. This case underscores the dangers of Ashwagandha, particularly for individuals with preexisting liver conditions, where it can lead to life-threatening acute-on-chronic liver failure. The lack of solid clinical evidence supporting Ashwagandha's health claims emphasizes the need for an evidence-based approach. Public education is essential to raise awareness of the risks associated with herbal supplements and prevent liver diseases.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article